Designates last full week of September of each year as "Frontotemporal Degeneration Awareness Week" in NJ.
Impact
Currently, it is estimated that about 40 percent of individuals living with FTD have a family history of the disease or related conditions such as amyotrophic lateral sclerosis. Moreover, FTD often goes misdiagnosed as other psychiatric conditions or neurodegenerative diseases, which complicates the understanding and treatment of affected individuals. By raising awareness through a designated week, it is hoped that both the recognition of FTD and the necessary support for patients will improve, thereby enhancing the overall quality of care.
Summary
Assembly Joint Resolution No. 77 aims to designate the last full week of September each year as 'Frontotemporal Degeneration Awareness Week' in New Jersey. This initiative seeks to raise public awareness about frontotemporal degeneration (FTD), a terminal and incurable neurodegenerative disease that primarily affects the frontal and temporal lobes of the brain. The designation intends to inform New Jersey citizens about the impacts of FTD, which include impairments to speech, personality, behavior, and motor skills.
Contention
The resolution underscores the need for increased research and public engagement surrounding FTD, especially considering that it is the most common form of dementia in individuals under 60. Acknowledging the unique challenges posed by FTD, such as the longer time to diagnosis and higher annual care costs compared to other types of dementia, adds urgency to the efforts for public awareness. The resolution reflects a growing recognition of the need for attention and resources focused on neurodegenerative diseases, which often are overshadowed by more commonly recognized forms of dementia like Alzheimer's.
Additional_information
This joint resolution represents a proactive approach from the New Jersey Legislature to recognize and address the public health challenges posed by FTD. By designating an awareness week, the state seeks to facilitate discussions on the socioeconomic impacts of the disease and ultimately drive forward a better understanding of frontotemporal dementia.